Brief: Argenx Announces Approval Of VYVDURA In Japan
27/12/2024 06:06
Dec 27 (Reuters) - argenx SE ARGX.BR :
* ARGENX ANNOUNCES APPROVAL OF VYVDURA (EFGARTIGIMOD ALFA
AND
HYALURONIDASE-QVFC) IN JAPAN FOR ADULTS WITH CHRONIC
INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Source text: ID:nGNE4KvJXK
Further company coverage: ARGX.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))